Hologic
HOLX
Performance
About Hologic
Hologic is a global medical technology company focused on improving women’s health through early detection and proactive treatment. It develops and markets imaging, diagnostic, and therapeutic technologies with an emphasis on breast health, gynecological health, and related diagnostic solutions, serving customers worldwide. The company emphasizes AI-powered approaches and advanced lab technologies to enhance cancer detection and overall women's health outcomes across multiple countries. Headquartered in the United States, Hologic operates in a global network of subsidiaries and regional offices.
Recent News
Hologic CEO Steve MacMillan to Retire After Go-Private Deal
Market Update: NFLX, DAL
Will the Iran Truce Hold? Where to Invest—Whether It Fizzles or Settles In
Globalstar Stock Rises on Amazon Takeover. The Impact on AST SpaceMobile and Iridium.
José ‘Joe’ Almeida Named CEO of Hologic After $18 B Private‑Equity Deal
Apple Gaining Market Share In PCs, Smartphones
Advent, Avista, Main Post Bet on Personal Care; Underinvested Women’s Health Draws in Private Equity
US Private Credit Market Expands Significantly in Early 2026, Report Reveals
Anthropic’s New AI Model Triggered an Emergency Banking Meeting. It’s a Reason to Buy Cybersecurity Stocks.
Blackstone and TPG Finalize $6.3 B Hologic Buyout, Appoint Former Baxter CEO Joe Almeida
José Almeida Named CEO of Hologic After $18 B Blackstone‑TPG Buyout
TSMC Tops Q1 Sales Target On Strong AI Chip Demand
Hologic Hires Former Baxter International Chief as Next CEO
#58773
Recent Deals
No recent deals for this company.
